MediPrint Ophthalmics

MediPrint Ophthalmics is an emerging clinical-stage ophthalmic care pharmaceutical company developing and commercializing a proprietary portfolio of ocular drug delivery products, initially focused on glaucoma, dry eye, and ocular allergies. We are utilizing our proprietary MediPrint™ process to develop, clinically test, and commercialize drug-eluting, enhanced-comfort contact lenses to treat millions of patients worldwide without the need for eye drops. We aim to address various unmet ocular care needs, all with significant market opportunities.